Anthropometric features and cardiovascular risk in young Latin Americans with type 2 diabetes mellitus

Journal of Diabetes and Its Complications
Larissa Avilés-SantaPhilip Raskin

Abstract

The purpose of this study is to compare score systems used to estimate the risk for cardiovascular disease (CVD) in young patients with poorly controlled type 2 diabetes. Fifty-seven Latin American patients with type 2 diabetes, between the ages 18 and 45 years, were screened to participate in a clinical research study evaluating the effects of intensive insulin therapy on both traditional and nontraditional CVD risk factors. All women were premenopausal and had regular menstrual periods. Baseline reviews of cardiovascular (CV) risk scores, personal history, physical examination, and laboratory screening were performed. The Framingham Study Score system and the presence of features of the metabolic syndrome (MSyn) were recorded and compared. Both genders had a comparable number of features of the MSyn, whereas according to the Framingham Score System, men had a slightly higher risk of CVD. The Framingham Score system is not an accurate device to estimate risk of CVD in premenopausal women with type 2 diabetes mellitus, who otherwise have a multiple features of the MSyn. If used to estimate risk of CVD, the Framingham score system could underestimate the risk of CVD in both young men and women with type 2 diabetes mellitus.

References

May 11, 1979·JAMA : the Journal of the American Medical Association·W B Kannel, D L McGee
Jul 1, 1991·Diabetes Care·S M HaffnerH P Hazuda
Feb 6, 1991·JAMA : the Journal of the American Medical Association·E L Barrett-ConnorS L Edelstein
Aug 5, 2000·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·K M Flegal, R P Troiano
Jul 16, 2003·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·F E von EybenR von Eyben
Sep 6, 2003·The American Journal of Cardiology·Willa A Hsueh, Manuel J Quiñones
Oct 1, 2003·Circulation·Steven Haffner, Heinrich Taegtmeyer
Oct 22, 2003·Obesity Research·Earl S FordWayne H Giles
Feb 13, 2004·Progress in Cardiovascular Diseases·Suzanne R Steinbaum
Jun 17, 2004·JAMA : the Journal of the American Medical Association·Allison A HedleyKatherine M Flegal
Oct 2, 2004·International Journal of Cardiology·Alexander TenenbaumEnrique Z Fisman
Jan 12, 2005·Journal of Diabetes and Its Complications·Annika DotevallAnnika Rosengren

❮ Previous
Next ❯

Citations

Dec 17, 2014·Journal of Diabetes and Metabolic Disorders·Manouchehr NakhjavaniAlireza Esteghamati
Apr 16, 2013·Journal of Cutaneous Medicine and Surgery·Kim PappAndrew Vieira
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.